Billable/Specific ICD-10-CM Codes - Page 29
There are 35,750 ICD-10-CM codes which are billable/specific and can be used to indicate a diagnosis for reimbursement purposes as there are no codes with a greater level of specificity under each code.
- D57.432 - Sickle-cell thalassemia beta zero with splenic sequestration
- D57.433 - Sickle-cell thalassemia beta zero with cerebral vascular involvement
- D57.434 - Sickle-cell thalassemia beta zero with dactylitis
- D57.438 - Sickle-cell thalassemia beta zero with crisis with other specified complication
- D57.439 - Sickle-cell thalassemia beta zero with crisis, unspecified
- D57.44 - Sickle-cell thalassemia beta plus without crisis
- D57.451 - Sickle-cell thalassemia beta plus with acute chest syndrome
- D57.452 - Sickle-cell thalassemia beta plus with splenic sequestration
- D57.453 - Sickle-cell thalassemia beta plus with cerebral vascular involvement
- D57.454 - Sickle-cell thalassemia beta plus with dactylitis
- D57.458 - Sickle-cell thalassemia beta plus with crisis with other specified complication
- D57.459 - Sickle-cell thalassemia beta plus with crisis, unspecified
- D57.80 - Other sickle-cell disorders without crisis
- D57.811 - Other sickle-cell disorders with acute chest syndrome
- D57.812 - Other sickle-cell disorders with splenic sequestration
- D57.813 - Other sickle-cell disorders with cerebral vascular involvement
- D57.814 - Other sickle-cell disorders with dactylitis
- D57.818 - Other sickle-cell disorders with crisis with other specified complication
- D57.819 - Other sickle-cell disorders with crisis, unspecified
- D58.0 - Hereditary spherocytosis
- D58.1 - Hereditary elliptocytosis
- D58.2 - Other hemoglobinopathies
- D58.8 - Other specified hereditary hemolytic anemias
- D58.9 - Hereditary hemolytic anemia, unspecified
- D59.0 - Drug-induced autoimmune hemolytic anemia
- D59.10 - Autoimmune hemolytic anemia, unspecified
- D59.11 - Warm autoimmune hemolytic anemia
- D59.12 - Cold autoimmune hemolytic anemia
- D59.13 - Mixed type autoimmune hemolytic anemia
- D59.19 - Other autoimmune hemolytic anemia
- D59.2 - Drug-induced nonautoimmune hemolytic anemia
- D59.30 - Hemolytic-uremic syndrome, unspecified
- D59.31 - Infection-associated hemolytic-uremic syndrome
- D59.32 - Hereditary hemolytic-uremic syndrome
- D59.39 - Other hemolytic-uremic syndrome
- D59.4 - Other nonautoimmune hemolytic anemias
- D59.5 - Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]
- D59.6 - Hemoglobinuria due to hemolysis from other external causes
- D59.8 - Other acquired hemolytic anemias
- D59.9 - Acquired hemolytic anemia, unspecified
- D60.0 - Chronic acquired pure red cell aplasia
- D60.1 - Transient acquired pure red cell aplasia
- D60.8 - Other acquired pure red cell aplasias
- D60.9 - Acquired pure red cell aplasia, unspecified
- D61.01 - Constitutional (pure) red blood cell aplasia
- D61.02 - Shwachman-Diamond syndrome
- D61.03 - Fanconi anemia
- D61.09 - Other constitutional aplastic anemia
- D61.1 - Drug-induced aplastic anemia
- D61.2 - Aplastic anemia due to other external agents
- D61.3 - Idiopathic aplastic anemia
- D61.810 - Antineoplastic chemotherapy induced pancytopenia
- D61.811 - Other drug-induced pancytopenia
- D61.818 - Other pancytopenia
- D61.82 - Myelophthisis
- D61.89 - Other specified aplastic anemias and other bone marrow failure syndromes
- D61.9 - Aplastic anemia, unspecified
- D63.0 - Anemia in neoplastic disease
- D63.1 - Anemia in chronic kidney disease
- D63.8 - Anemia in other chronic diseases classified elsewhere
- D64.0 - Hereditary sideroblastic anemia
- D64.1 - Secondary sideroblastic anemia due to disease
- D64.2 - Secondary sideroblastic anemia due to drugs and toxins
- D64.3 - Other sideroblastic anemias
- D64.4 - Congenital dyserythropoietic anemia
- D64.81 - Anemia due to antineoplastic chemotherapy
- D64.89 - Other specified anemias
- D64.9 - Anemia, unspecified
- D68.00 - Von Willebrand disease, unspecified
- D68.01 - Von Willebrand disease, type 1
- D68.020 - Von Willebrand disease, type 2A
- D68.021 - Von Willebrand disease, type 2B
- D68.022 - Von Willebrand disease, type 2M
- D68.023 - Von Willebrand disease, type 2N
- D68.029 - Von Willebrand disease, type 2, unspecified
- D68.03 - Von Willebrand disease, type 3
- D68.04 - Acquired von Willebrand disease
- D68.09 - Other von Willebrand disease
- D68.1 - Hereditary factor XI deficiency
- D68.2 - Hereditary deficiency of other clotting factors
- D68.311 - Acquired hemophilia
- D68.312 - Antiphospholipid antibody with hemorrhagic disorder
- D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
- D68.32 - Hemorrhagic disorder due to extrinsic circulating anticoagulants
- D68.4 - Acquired coagulation factor deficiency
- D68.51 - Activated protein C resistance
- D68.52 - Prothrombin gene mutation
- D68.59 - Other primary thrombophilia
- D68.61 - Antiphospholipid syndrome
- D68.62 - Lupus anticoagulant syndrome
- D68.69 - Other thrombophilia
- D68.8 - Other specified coagulation defects
- D68.9 - Coagulation defect, unspecified
- D69.0 - Allergic purpura
- D69.1 - Qualitative platelet defects
- D69.2 - Other nonthrombocytopenic purpura
- D69.3 - Immune thrombocytopenic purpura
- D69.41 - Evans syndrome
- D69.42 - Congenital and hereditary thrombocytopenia purpura
- D69.49 - Other primary thrombocytopenia